Henry N. Young, PhD

home / authors / henry-n-young-phd

Articles

June 13th 2024

Innovation, Affordability, Access: Alzheimer Disease Drugs and the Inflation Reduction Act

Niying Li, PhD, MSc Smita Rawal, PhD Henry N. Young, PhD Lorenzo Villa Zapata, PhD

The authors explore the economic impact and accessibility challenges of new Alzheimer disease drugs under the Inflation Reduction Act, with emphasis on Medicare, pricing, and health care equity.

September 1st 2006

Physicians' Perceptions of Relevant Prescription Drug Costs: Do Costs to the Individual Patient or to the Population Matter Most?

William H. Shrank, MD, MSHS George J. Joseph, MS Niteesh K. Choudhry, MD, PhD Henry N. Young, PhD Susan L. Ettner, PhD Peter Glassman, MBBS, MSc Steven M. Asch, MD, MPH Richard L. Kravitz, MD, MSPH

January 15th 2005

Do the Incentives in 3-Tier Pharmaceutical Benefit Plans Operate as Intended? Results From a Physician Leadership Survey

William H. Shrank, MD, MSHS Henry N. Young, PhD Susan L. Ettner, PhD Peter Glassman, MBBS, MSc Steven M. Asch, MD, MPH Richard L. Kravitz

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: December 17th 2024 | Updated: December 22nd 2024

ICYMI: Highlights From IMS 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions